Literature DB >> 1269875

Quinidine hepatotoxicity. A report of a case and review of the literature.

M J Koch, L B Seeff, C E Crumley, L Rabin, W A Burns.   

Abstract

A case is described of presumed quinidine hepatotoxicity, characterized by the development of fever, abnormal serum transaminase values, which improved after cessation of the drug but recurred after a challenge dose, and centrizonal hepatocellular necrosis detected on liver biopsy. Morphological changes on electron microscopy, consistent with a drug reaction, are also described. Pertinent features of previous case reports are analyzed, and the histological findings by light microscopy of the present and past cases are discussed. It is suggested that the development of unexplained fever within 1 month of quinidine administration should lead to consideration of possible hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269875

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

Review 2.  Drug-induced liver disease.

Authors:  H J Zimmerman
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 3.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

4.  Quinine-induced granulomatous hepatitis.

Authors:  B Katz; M Weetch; S Chopra
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-22

Review 5.  Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig; R Axelsen
Journal:  Dig Dis Sci       Date:  1983-07       Impact factor: 3.199

6.  Quinidine hypersensitivity: a side effect of a forgotten antiarrhythmic.

Authors:  Layan El-Khatib; Hussayn Alrayes; Omar Sallam; Ahmed Elbanna
Journal:  BMJ Case Rep       Date:  2020-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.